CHIR Chiron (MM)

First graph, first sentence of release should read: Chiron Corporation (NASDAQ:CHIR) today announced that it will convene a special meeting of stockholders on Wednesday, April 12, 2006, to vote to approve its proposed merger with Novartis AG (sted Tuesday, April 18, 2006). The corrected release reads: CHIRON SCHEDULES SPECIAL MEETING OF STOCKHOLDERS TO APPROVE MERGER WITH NOVARTIS Chiron Corporation (NASDAQ:CHIR) today announced that it will convene a special meeting of stockholders on Wednesday, April 12, 2006, to vote to approve its proposed merger with Novartis AG. The meeting will be held at 8:30 a.m. PDT at Chiron's headquarters at 1450 53rd Street, Emeryville, California 94608. Stockholders at the close of business on the record date of March 3, 2006, will be eligible to vote at the special meeting. Chiron anticipates filing its definitive proxy statement with the Securities and Exchange Commission on or about Friday, March 3, 2006. About Chiron Chiron delivers innovative and valuable products to protect human health by advancing pioneering science across the landscape of biotechnology. The company works to deliver on the limitless promise of science and make a positive difference in people's lives. For more information about Chiron, please visit www.chiron.com. Forward-Looking Statements This news release contains forward-looking statements, including statements regarding the date of the special meeting of stockholders and the filing of the definitive proxy statement with the SEC. These statements are subject to a number of risks and uncertainties and are subject to change. There can be no assurance that the special meeting will be held as described or that the proxy statement will be filed on the date indicated. Chiron does not undertake an obligation to update the forward-looking information the company is giving today. Participants in Solicitation Chiron Corporation and Novartis AG and Novartis Corporation and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from Chiron stockholders in connection with the merger. Information about the directors and executive officers of Chiron and their ownership of Chiron's stock is set forth in the proxy statement for Chiron's 2005 Annual Meeting of Stockholders. Investors can obtain more information when the definitive proxy statement for the proposed merger becomes available. Investors should read the definitive proxy statement and Schedule 13E-3 carefully before making any voting decision.